Brief: Urogen Pharma- Announces $75 Mln Of Non-Dilutive Funding From Rtw Investments
18/03/2021 12:35
March 18 (Reuters) - Urogen Pharma Ltd UR8.F :
* UROGEN PHARMA LTD - ANNOUNCES $75 MILLION OF NON-DILUTIVE
FUNDING FROM RTW INVESTMENTS
* UROGEN PHARMA LTD - ANNOUNCES $75 MILLION OF NON-DILUTIVE
FUNDING FROM RTW INVESTMENTS
* UROGEN PHARMA - RTW INVESTMENTS, LP WILL GET TIERED FUTURE
PAYMENTS BASED ON WORLDWIDE ANNUAL NET PRODUCT SALES OF JELMYTO
AND UGN-102, IF APPROVED
Source text for Eikon: ID:nBwVWkmJa
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors